These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1893962

  • 1. Age-related changes in various hemopoietic progenitor cells in senescence-accelerated (SAM-P) mice.
    Tsuboi I, Morimoto K, Horie T, Mori KJ.
    Exp Hematol; 1991 Oct; 19(9):874-7. PubMed ID: 1893962
    [Abstract] [Full Text] [Related]

  • 2. Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice.
    Goris H, Bungart B, Loeffler M, Schmitz S, Nijhof W.
    Exp Hematol; 1990 Jun; 18(5):400-7. PubMed ID: 2338129
    [Abstract] [Full Text] [Related]

  • 3. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 5. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 6. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Sep; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 8. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
    Van Zant G, Shultz L.
    Exp Hematol; 1989 Feb; 17(2):81-7. PubMed ID: 2783574
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG.
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [Abstract] [Full Text] [Related]

  • 11. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 12. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 13. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 14. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 15. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC.
    Exp Hematol; 1994 Mar 15; 22(3):302-12. PubMed ID: 8112428
    [Abstract] [Full Text] [Related]

  • 16. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 17. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 15; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M, Chiba S, Kikuchi M, Tsukada J, Sato T, Oda S, Eto S.
    Int J Cell Cloning; 1989 Jan 15; 7(1):39-49. PubMed ID: 2465360
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.